KINRIX
Active immunization against diphtheria, tetanus, pertussis, and poliomyelitis as the fifth dose in the diphtheria, tetanus, and acellular pertussis (DTaP) vaccine series and the fourth dose in the inactivated poliovirus vaccine (IPV) series in children 4 through 6 years of age whose previous DTaP vaccine doses have been with INFANRIX® and/or PEDIARIX® for the first three doses and INFANRIX® for the fourth dose.
Found 9141 cases where Vaccine is DTAPIPV
- November 6, 2019 Approval Letter – KINRIX
- Approval History, Letters, Reviews, and Related Documents – KINRIX
- Supporting Documents older than three years – KINRIX
November 28, 2019 – Aluminum granuloma in a child secondary to DTaP‐IPV vaccination: A case report “To our knowledge, this is the first report describing the development of an aluminum granuloma causing a persistent, pruritic nodule at the injection site following the administration of the DTaP‐IPV vaccine. We present the case of a 6‐year‐old girl who developed a severely pruritic subcutaneous nodule on her anterior right thigh at the injection site three weeks after the administration of the aluminum‐containing DTaP‐IPV (Kinrix) vaccine.”
January 9, 2014 – Kinrix™: a new combination DTaP–IPV vaccine for children aged 4–6 years “Combination vaccines allow the administration of multiple vaccine antigens without the need for multiple injections. Recently, a combined diphtheria toxoid, tetanus toxoid, acellular pertussis and inactivated poliomyelitis vaccine (DTaP–IPV), Kinrix™, has been licensed in the USA for use as the fifth DTaP dose and fourth IPV dose in children 4–6 years of age. … Strategies such as the use of combined vaccines can help to maintain high levels of coverage against diphtheria, tetanus, pertussis and poliomyelitis diseases.”
March 3, 2010 – New Combination Vaccines: DTaP-IPV (Kinrix) and DTaP-IPV/Hib (Pentacel) “DTaP-IPV and DTaP-IPV/Hib combination vaccines are immunogenic and safe when given to infants and children. They reduce the number of required injections. Combination vaccines are encouraged to promote timely vaccination and complete immunization schedules.”
January 9, 2014 – Kinrix™: a new combination DTaP–IPV vaccine for children aged 4–6 years “Combination vaccines allow the administration of multiple vaccine antigens without the need for multiple injections. Recently, a combined diphtheria toxoid, tetanus toxoid, acellular pertussis and inactivated poliomyelitis vaccine (DTaP–IPV), Kinrix™, has been licensed in the USA for use as the fifth DTaP dose and fourth IPV dose in children 4–6 years of age. … Strategies such as the use of combined vaccines can help to maintain high levels of coverage against diphtheria, tetanus, pertussis and poliomyelitis diseases.”
March 3, 2010 – New Combination Vaccines: DTaP-IPV (Kinrix) and DTaP-IPV/Hib (Pentacel) “DTaP-IPV and DTaP-IPV/Hib combination vaccines are immunogenic and safe when given to infants and children. They reduce the number of required injections. Combination vaccines are encouraged to promote timely vaccination and complete immunization schedules.”